INSIGHTS ON CLINICAL TRIAL DESIGN
-
Diversity In Clinical Trials Is A Design Decision, Not An Outreach Plan
Build more diverse trials through trusted community ties, physician networks, representative research teams, and intentional site design that support enrollment and retention.
-
How To Accelerate Early-Phase Oncology Trial
Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.
-
How In-Home Trials Can Shift The Pediatric Rare Disease Research Landscape
DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.
-
Tracking Functional Capacity To Advance Neuromuscular Disease Research
This presentation introduces a dual-endpoint approach to monitoring neuromuscular disease progression through two high-centile digital measures.
-
Overcoming Challenges In Obesity Trials2/12/2026
Obesity trials face high dropout rates due to long durations and complex requirements. Overcome these hurdles with personalized engagement, expert lifestyle support, and proactive patient care.
-
The Difference Between Clinical Trial Auditing And Monitoring4/28/2025
While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.
-
Decentralized Trials Still Need Connected Support7/23/2026
Decentralized and hybrid trials reduce travel burdens but add coordination challenges. Strong support improves communication, engagement, and smooth trial execution from enrollment to completion.
-
What Drives Attendance And Engagement At Clinical Meetings?5/6/2026
A clear look at what drives attendance and engagement at clinical meetings, and how design decisions shape comprehension, retention, and consistency as programs scale globally over time.
-
Navigating Pediatric Clinical Trials: Challenges And Specific Strategies For Success5/2/2025
Advance your understanding of pediatric therapeutics with experts who will help you to navigate the complexities of designing age-specific trials and overcome specimen collection obstacles.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
-
Driven by AI and real-world data, Citeline PatientMatch helps sponsors identify highly qualified, protocol-matched patients earlier in their care journey — when enrollment decisions matter most.
-
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
-
Get near real-time notifications when a potential trial candidate presents in the clinic, which will help enable recruitment before the window of opportunity closes.
-
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.